Informations générales (source: ClinicalTrials.gov)
IMMunological ResPonse Assessment AfteR Acute ISchemic Stroke Treated with Endovascular Therapy (IMPRESS)
Observational
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
février 2023
mai 2028
26 mars 2025
IMPRESS study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles
during the first 24/36 hours of treatment of patients suffering from AIC treated with TM,
and to study the possible impact of these profiles on the functional prognosis at 3
months of AIC treatment.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL FONDATION A. DE ROTHSCHILD | Benjamin MAEIR | 21/06/2024 13:33:55 | Contacter | ||
Critères
Tous
Inclusion Criteria:
- Patient with an acute ischemic stroke for which treatment with mechanical
thrombectomy is indicated, whether or not thrombectomy is performed,
- Having received informed information about the study and having signed a consent to
participate in the study (if this is not possible: information and consent of the
trusted support person or family member if present; emergency inclusion if absent);
- Affiliated or beneficiary of a social security scheme or equivalent.
Non inclusion Criteria:
- Pregnant or breast-feeding women
- Patient benefiting from a legal protection measure
- Patient with an acute ischemic stroke for which treatment with mechanical
thrombectomy is indicated, whether or not thrombectomy is performed,
- Having received informed information about the study and having signed a consent to
participate in the study (if this is not possible: information and consent of the
trusted support person or family member if present; emergency inclusion if absent);
- Affiliated or beneficiary of a social security scheme or equivalent.
Non inclusion Criteria:
- Pregnant or breast-feeding women
- Patient benefiting from a legal protection measure
None.